FHIRsmith: FHIR Resources

FHIR IG analytics

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | kr | nl | no | nz | pl | pt | se | stt | tw | uk | us | uv
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

ValueSets, Realm US

14,182 resources

By Version

R2: 0
R2B: 0
R3: 54
R4: 14,034
R4B: 21
R5: 73
R6: 0

By Authority

none: 1,981
hl7: 12,201

Start Prev Rows 4800 - 5000 Next

Package	Version	Identity	Name/Title	Status	Date	Auth	Source(s)
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.345.json	PTEN_geneinterpretation	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.346.json	PIK3CA_gene	active	2024-07	hl7	ncit
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.347.json	PI3KCA_geneinterpretation	active	2024-07	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.348.json	AKTI_gene	active	2024-07	hl7	ncit
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.349.json	AKTI_geneinterpretation	active	2024-07	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.350.json	Progesterone_receptor_gene	active	2024-07	hl7	ncit
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.351.json	Progesterone_receptor_geneinterpretation	active	2024-07	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.352.json	Estrogen_receptor_gene	active	2024-07	hl7	ncit
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.353.json	Estrogen_receptor_geneinterpretation	active	2024-07	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.354.json	Progesterone_receptor_labtest	active	2024-07	hl7	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.355.json	Progesterone_receptor_labinterpretation	active	2024-07	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.356.json	Estrogen_receptor_labtest	active	2024-07	hl7	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.357.json	Estrogen_receptor_labinterpretation	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.358.json	NSCLC M0 Stage	active	2024-07	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.359.json	HER2_IHC_test_Gene	active	2024-08	hl7	ncit
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.360.json	HER2_IHC_test_Lab	active	2024-08	hl7	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.361.json	HER2_Fish_test	active	2024-08	hl7	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.362.json	HER2_IHC_Negative	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.363.json	Trodelvy	active	2024-08	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.364.json	Chemotherapy_breast_cancer	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.365.json	Cyclin_dependent_kinase	active	2024-08	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.366.json	Taxane_Trodelvy	active	2024-08	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.367.json	Endocrine_therapy	active	2024-08	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.368.json	HER2_Fish_test_Negative	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.369.json	HER2_IHC_Equivocal	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.370.json	HER2 Positive_PM_results	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.371.json	HER2 test_Lab	active	2024-08	hl7	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.372.json	HER2 test_gene	active	2024-08	hl7	ncit
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.374.json	Thyroid Cancer Diagnosis	active	2024-08	hl7	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.375.json	Metastatic_Thyroid_Stage Group	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.376.json	RET mutation_Molecular Variants	active	2024-08	hl7	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.377.json	RET Gene mutation	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.378.json	Locally_Advanced_Localized_Thyroid_Cancer_Stage Group	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.379.json	Thyroid cancer M1_Stage	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.380.json	Thyroid_cancer_M0_Stage	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.381.json	Thyroid_cancer_T_Stage	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.382.json	Thyroid_cancer_T1_T2_T3_Stage	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.383.json	Thyroid_cancer_T4_Stage	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.384.json	Thyroid_cancer_N1b_Stage&Above	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.385.json	Thyroid_cancer_N_Stage	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.386.json	Medullary_thyroid_histology	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.387.json	RET test_Thyroid_cancer (HGNC)	active	2024-08	hl7	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.388.json	RET Positive	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.389.json	NSCLC N3 Stage	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.390.json	CRC Cancer Diagnosis ICD9	active	2024-08	hl7	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.391.json	CRC Cancer Diagnosis ICD10	active	2024-08	hl7	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.392.json	CRC Cancer Diagnosis ICD9/ICD10	active	2024-08	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.393.json	Metastatic_CRC_Cancer_Stage Group	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.394.json	Locally_Advanced_Localized_CRC_Stage Group	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.395.json	CRC cancer M Stage (metastatic)	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.396.json	CRC Cancer T Stage	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.397.json	CRC Cancer N Stage	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.398.json	KRAS_gene	active	2024-08	hl7	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.399.json	KRAS_negative	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.40.json	Locoregional Breast Cancer	active	2023-10	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.400.json	Fluoropyrimidine_CRC	active	2024-08	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.401.json	Oxaliplatin	active	2024-08	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.402.json	Irinotecan_based_therapy	active	2024-08	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.403.json	anti_VEGF_therapy_CRC	active	2024-08	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.404.json	anti_EGFR_therapy_CRC	active	2024-08	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.405.json	fruquitinib	active	2024-08	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.406.json	Locally_Advanced_CRC_Stage Group	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.407.json	Localized_CRC_Stage Group	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.408.json	CRC cancer M0_Stage	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.409.json	CRC_Cancer_T1_Stage	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.410.json	CRC_Cancer_T2_Stage	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.411.json	CRC_Cancer_T3_Stage	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.412.json	CRC_Cancer_T4_Stage	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.413.json	CRC Cancer N1 Stage	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.414.json	CRC Cancer N2 Stage	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.415.json	CRC Cancer N2b Stage	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.416.json	KRAS_G12C_MV	active	2024-08	hl7	ncit
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.417.json	KRAS_G12C_PM	active	2024-08	hl7	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.418.json	KRAS_positive	active	2024-08	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.419.json	Adagrasib	active	2024-08	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.42.json	Breast Cancer	active	2023-10	hl7	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.420.json	cetuximab_therapy	active	2024-08	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.421.json	Tamoxifen_therapy	active	2024-08	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.423.json	Endometrial Cancer Diagnosis ICD 10	active	2024-09	hl7	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.425.json	Endometrial Cancer Diagnosis ICD9CM	active	2024-09	hl7	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.426.json	Endometrial Cancer Diagnosis	active	2024-09	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.428.json	Localized_Endometerial_Stage Group SNOMED	active	2024-09	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.429.json	Localized_Endometerial_Stage Group NCIM	active	2024-09	hl7	ncit
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.431.json	Endometrial_Sarcoma_Tumor_Histology_exc	active	2024-09	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.432.json	Endometrial cancer M Stage (metastatic)	active	2024-09	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.433.json	Endometrial_M0_Stage	active	2024-09	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.436.json	Prior_therapy_Endometrial	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.437.json	Paclitaxel_therapy	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.441.json	Carboplatin_therapy	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.442.json	Durvalumab_therapy	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.444.json	MMR_Gene_Lab_LOINC	active	2024-09	hl7	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.447.json	MMR_Gene_HGNC	active	2024-09	hl7	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.449.json	Endometrial_ Cancer N Stage	active	2024-09	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.451.json	Endometrial_N0_Stage	active	2024-09	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.453.json	Endometrial_N1_N2_Stage	active	2024-09	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.455.json	Endometrial_T1_T3_Stage	active	2024-09	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.456.json	Endometrial_T3_Stage	active	2024-09	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.458.json	Endometrial_T4_Stage	active	2024-09	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.459.json	Endometrial Cancer T Stage	active	2024-09	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.46.json	Endometrial Cancer ICD10	active	2023-11	hl7	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.460.json	Localized_Endometerial_Stage Group_SNOMED/NCIM	active	2024-09	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.461.json	Metastatic Sites All CRC	active	2024-09	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.462.json	Metastatic Sites All CRC ICD 10	active	2024-09	hl7	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.463.json	Metastatic Sites All CRC ICD 9	active	2024-09	hl7	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.464.json	Metastatic Sites All CRC (grouped, SNOMEDCT/ICD9/ICD10)	active	2024-09	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.465.json	NTRK Repotrectinib Molecular Variants	active	2024-09	hl7	ncit
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.466.json	NTRK_Gene_rearrangment	active	2024-09	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.467.json	Prior_Systemic_therapy_Repotrectinib	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.468.json	NTRK_Positive	active	2024-09	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.469.json	NTRK_test_gene	active	2024-09	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.47.json	Systemic treatment for endometrial cancer	active	2023-11	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.470.json	Tamoxifen_Trodelvy	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.471.json	Toremifene_trodelvy	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.472.json	Fulvestrant_Trodelvy	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.473.json	Elacestrant	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.474.json	Anastrozole_Trodelvy	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.475.json	Leuprolide_Trodelvy	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.476.json	Abemaciclib	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.477.json	Palbociclib	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.478.json	Ribociclib	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.479.json	Carboplatin_Trodelvy	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.48.json	Endometrial Cancers	active	2023-11	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.480.json	Cisplatin_Trodelvy	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.481.json	Cyclophosphamide	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.482.json	Methotrexate	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.483.json	Gemcitabine	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.484.json	Capecitabine	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.485.json	Eribulin	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.486.json	Doxorubicin	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.487.json	Vinorelbine	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.488.json	Epirubicin	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.489.json	Ixabepilone	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.490.json	Olaparib	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.491.json	Talazoparib	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.492.json	Entrectinib	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.493.json	larotrectinib	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.494.json	Alpelisib	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.495.json	Capivasertib	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.496.json	Pembrolizumab	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.497.json	Dostarlimab	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.498.json	Selpercatinib	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.499.json	Everolimus	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.500.json	Trastuzumab_deruxtecan	active	2024-09	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.501.json	Test 23	active	2024-09	hl7	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.502.json	All Metastatic sites Endometrial SNOMED	active	2024-09	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.503.json	All Metastatic sites Endometrial ICD9	active	2024-09	hl7	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.504.json	All Metastatic sites Endometrial ICD10	active	2024-09	hl7	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.505.json	All Metastatic sites Endometrial	active	2024-09	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.506.json	Create CRC_Cancer_T4a_Stage	active	2024-10	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.507.json	Create CRC_Cancer_T4b_Stage	active	2024-10	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.508.json	High Emetogenic Risk Chemotherapy	active	2025-04	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.510.json	InactiveFollowup	active	2025-05	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.53.json	MMR Gene Testing	active	2023-11	hl7	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.54.json	MSI High	active	2023-11	hl7	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.55.json	MSI High	active	2024-01	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.6.json	Orserdu	active	2023-08	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.61.json	Stage IIB or lower and limited	active	2023-11	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.62.json	Stage III or higher	active	2023-11	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.63.json	Stage III or higher	active	2023-11	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.64.json	Stage III or higher	active	2023-11	hl7	ncit
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.65.json	Staging Unknown	active	2023-11	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.66.json	Staging Unknown	active	2023-11	hl7	ncit
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.67.json	Staging Unknown	active	2023-11	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.68.json	Jemperli	active	2023-11	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.69.json	Uterine Sarcoma	active	2023-11	hl7	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.7.json	Her2 Test For Orserdu	active	2023-09	hl7	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.70.json	Tumor Histology	active	2023-11	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.71.json	Platinum based therapy	active	2023-11	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.72.json	Prior Therapies for Tucatinib	active	2023-12	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.73.json	Tucatinib	active	2023-12	hl7	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.74.json	Colorectal Cancer ICD10	active	2023-12	hl7	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.75.json	Colorectal Cancer ICD9	active	2023-12	hl7	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.76.json	Colorectal Cancer ICD9 and ICD10	active	2023-12	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.78.json	Advanced or Unresectable Colorectal Cancer Staging	active	2023-12	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.79.json	0 to IIIB Colorectal Cancer Staging	active	2023-12	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.80.json	Colorectal Cancer M1 Stage	active	2023-12	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.81.json	RAS Genes	active	2023-12	hl7	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.82.json	RAS Gene Interpretation Negative LOINC	active	2023-12	hl7	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.83.json	RAS Gene Interpretation Negative SNOMED	active	2023-12	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.84.json	RAS Gene Interpretation Negative NCM	active	2023-12	hl7	ncit
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.85.json	RAS Gene Negative	active	2023-12	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.86.json	RAS Gene Interpretation Positive SNOMED	active	2023-12	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.87.json	RAS Gene Interpretation Positive LOINC	active	2023-12	hl7	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.88.json	RAS Gene Positive	active	2023-12	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.89.json	Her2 Testing	active	2023-12	hl7	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.90.json	Patient Reason	active	2023-12	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.91.json	MSI High NCI	active	2024-01	hl7	ncit
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.92.json	MSI Low SNOMED	active	2024-01	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.93.json	MSI Low LOINC	active	2024-01	hl7	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.94.json	MSI Low NCI	active	2024-01	hl7	ncit
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.95.json	MSI Low	active	2024-01	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.96.json	MMR Deficient NCI	active	2024-01	hl7	ncit
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.97.json	MMR Proficient SNOMED	active	2024-01	hl7	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.98.json	MMR Proficient LOINC	active	2024-01	hl7	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1260.99.json	MMR Proficient NCI	active	2024-01	hl7	ncit
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1262.3.json	ICD9 Codes for HIV Diagnosis	active	2023-10	hl7	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1264.1.json	Inpatient Pneumonia Diagnosis	active	2023-12	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1264.11.json	Chest Imaging for Pneumonia, HCPCS	active	2023-11	hl7	cms
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1264.12.json	Chest Imaging for Pneumonia Grouping Definition	active	2024-09	hl7	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1264.18.json	ICD9 Abnormal Finding on Chest Imaging	active	2023-12	hl7	icd